GEREF Drug Patent Profile
✉ Email this page to a colleague
When do Geref patents expire, and what generic alternatives are available?
Geref is a drug marketed by Emd Serono and Emd Serono Inc and is included in two NDAs.
The generic ingredient in GEREF is sermorelin acetate. There is one drug master file entry for this compound. Additional details are available on the sermorelin acetate profile page.
Summary for GEREF
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 25 |
Patent Applications: | 296 |
DailyMed Link: | GEREF at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for GEREF
US Patents and Regulatory Information for GEREF
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Emd Serono | GEREF | sermorelin acetate | INJECTABLE;INJECTION | 019863-001 | Dec 28, 1990 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Emd Serono Inc | GEREF | sermorelin acetate | INJECTABLE;INJECTION | 020443-001 | Sep 26, 1997 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Emd Serono Inc | GEREF | sermorelin acetate | INJECTABLE;INJECTION | 020443-002 | Sep 26, 1997 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for GEREF
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Emd Serono | GEREF | sermorelin acetate | INJECTABLE;INJECTION | 019863-001 | Dec 28, 1990 | ⤷ Try a Trial | ⤷ Try a Trial |
Emd Serono Inc | GEREF | sermorelin acetate | INJECTABLE;INJECTION | 020443-002 | Sep 26, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Emd Serono Inc | GEREF | sermorelin acetate | INJECTABLE;INJECTION | 020443-002 | Sep 26, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Emd Serono Inc | GEREF | sermorelin acetate | INJECTABLE;INJECTION | 020443-001 | Sep 26, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Emd Serono | GEREF | sermorelin acetate | INJECTABLE;INJECTION | 019863-001 | Dec 28, 1990 | ⤷ Try a Trial | ⤷ Try a Trial |
Emd Serono Inc | GEREF | sermorelin acetate | INJECTABLE;INJECTION | 020443-001 | Sep 26, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for GEREF
See the table below for patents covering GEREF around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Czechoslovakia | 272758 | METHOD OF PEPTIDE PRODUCTION | ⤷ Try a Trial |
European Patent Office | 0146210 | GRF ANALOGS | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 8401379 | ⤷ Try a Trial | |
South Africa | 8502919 | ⤷ Try a Trial | |
Hungary | 191263 | PROCESS FOR PRODUCING FACTOR FOR PROMOTING LETTING OUT GROWTH HORMONE OF HUMAN PANCREATIC ORIGINE | ⤷ Try a Trial |
Spain | 8606412 | ⤷ Try a Trial | |
Yugoslavia | 77185 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |